Johnson & Johnson (JNJ) vs Eli Lilly and Company (LLY)
See how Johnson & Johnson and Eli Lilly and Company differ across market data and performance, so you can decide which asset best fits your strategy.
$255.56
NYSE
Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.
View Full Page$1,257.03
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full PageKey Metrics Comparison
Johnson & JohnsonJNJ
Market Cap$615.874B
Price$255.56
24h Change+0.90%
24h Volume$6.39M
Employees138,200
Shares Outstanding2,407,216,971
Eli Lilly and CompanyLLY
Market Cap$1.12T
Price$1,257.03
24h Change+0.43%
24h Volume$2.41M
Employees50,000
Shares Outstanding944,818,881
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
JNJ
35.5%LLY
64.5%Volume Share
Share of combined 24h volume
JNJ
72.6%LLY
27.4%24h Performance
Price change over last 24 hours
JNJ
0.90%LLY
0.43%Price Comparison
Johnson & Johnson
Eli Lilly and Company